Jefferies Financial Group Inc. lessened its position in Colgate-Palmolive Company (NYSE:CL – Free Report) by 86.2% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 28,796 shares of the company’s stock after selling 179,493 shares during the period. Jefferies Financial Group Inc.’s holdings in Colgate-Palmolive were worth $2,457,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Cooper Financial Group grew its position in Colgate-Palmolive by 4.0% in the 2nd quarter. Cooper Financial Group now owns 2,947 shares of the company’s stock valued at $270,000 after purchasing an additional 114 shares during the period. Gould Capital LLC raised its holdings in Colgate-Palmolive by 38.7% during the first quarter. Gould Capital LLC now owns 412 shares of the company’s stock worth $35,000 after buying an additional 115 shares during the last quarter. Redhawk Wealth Advisors Inc. lifted its stake in shares of Colgate-Palmolive by 2.8% in the second quarter. Redhawk Wealth Advisors Inc. now owns 4,326 shares of the company’s stock valued at $397,000 after buying an additional 118 shares in the last quarter. SVB Wealth LLC lifted its stake in shares of Colgate-Palmolive by 1.4% in the second quarter. SVB Wealth LLC now owns 8,767 shares of the company’s stock valued at $804,000 after buying an additional 119 shares in the last quarter. Finally, Sowell Financial Services LLC grew its holdings in shares of Colgate-Palmolive by 2.1% during the third quarter. Sowell Financial Services LLC now owns 5,737 shares of the company’s stock valued at $490,000 after buying an additional 119 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.
Insiders Place Their Bets
In other news, COO Panagiotis Tsourapas sold 19,938 shares of the stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $98.74, for a total transaction of $1,968,678.12. Following the completion of the transaction, the chief operating officer directly owned 9,111 shares of the company’s stock, valued at $899,620.14. This represents a 68.64% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Gregory Malcolm sold 4,100 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $97.97, for a total transaction of $401,677.00. Following the completion of the sale, the executive vice president directly owned 10,061 shares in the company, valued at $985,676.17. This trade represents a 28.95% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 77,414 shares of company stock valued at $7,613,786. 0.43% of the stock is owned by company insiders.
Colgate-Palmolive Trading Down 0.1%
NYSE:CL opened at $99.62 on Monday. Colgate-Palmolive Company has a 52 week low of $75.96 and a 52 week high of $101.18. The firm has a 50-day moving average price of $90.94 and a two-hundred day moving average price of $90.29. The company has a debt-to-equity ratio of 11.23, a quick ratio of 0.63 and a current ratio of 0.96. The firm has a market cap of $79.19 billion, a price-to-earnings ratio of 39.07, a price-to-earnings-growth ratio of 4.51 and a beta of 0.31.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its earnings results on Friday, October 30th. The company reported $0.97 earnings per share for the quarter, topping analysts’ consensus estimates of $0.93 by $0.04. The firm had revenue of $5.37 billion for the quarter, compared to the consensus estimate of $5.34 billion. Colgate-Palmolive had a return on equity of 607.88% and a net margin of 9.65%. The company’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.91 EPS. On average, equities analysts expect that Colgate-Palmolive Company will post 3.92 earnings per share for the current fiscal year.
Colgate-Palmolive Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th were paid a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date was Tuesday, October 20th. Colgate-Palmolive’s dividend payout ratio is 83.14%.
Colgate-Palmolive News Summary
Here’s some of the latest news about CL:
- Positive Sentiment: Zacks Research raised its FY2026 EPS estimate to $3.91 from $3.85, close to the $3.92 consensus, and nudged its FY2027 and FY2028 forecasts higher to $4.06 and $4.38, respectively. These revisions suggest modest confidence in longer-term earnings growth. Zacks Research Has Bullish Forecast for CL FY2026 Earnings
- Neutral Sentiment: A comparison with Kimberly-Clark highlighted Colgate-Palmolive’s leading global oral-care position and its pet-nutrition business as potential growth diversifiers, but the article did not report a new company-specific catalyst. Colgate-Palmolive vs. Kimberly-Clark
- Negative Sentiment: A Colgate-Palmolive executive vice president sold $401,677 worth of company shares. Insider sales can weigh on sentiment, although a single transaction does not necessarily indicate a change in the company’s outlook. Insider Selling: Colgate-Palmolive EVP Sells Stock
Analyst Ratings Changes
Several research firms have recently commented on CL. Barclays boosted their target price on shares of Colgate-Palmolive from $87.00 to $95.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 3rd. TD Cowen lifted their price target on Colgate-Palmolive from $90.00 to $97.00 and gave the company a “hold” rating in a research note on Monday, November 2nd. Deutsche Bank reissued a “buy” rating and set a $101.00 price objective (up from $99.00) on shares of Colgate-Palmolive in a report on Monday, August 3rd. Royal Bank Of Canada increased their price objective on Colgate-Palmolive from $104.00 to $105.00 and gave the stock an “outperform” rating in a research note on Monday, November 2nd. Finally, Bank of America raised their target price on Colgate-Palmolive from $100.00 to $105.00 and gave the company a “buy” rating in a report on Monday, November 2nd. Thirteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $101.22.
View Our Latest Report on Colgate-Palmolive
About Colgate-Palmolive
Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food. The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world. Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.
Read More
- Five stocks we like better than Colgate-Palmolive
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
